Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales

被引:0
作者
Úna McMenamin
Blánaid Hicks
Carmel Hughes
Peter Murchie
Julia Hippisley-Cox
Tom Ranger
Carol Coupland
Chris Cardwell
机构
[1] Queen’s University Belfast,Centre for Public Health, ICSB
[2] Queen’s University Belfast,School of Pharmacy
[3] Academic Primary Care,Division of Applied Health Sciences Section
[4] University of Oxford,Primary Care Epidemiology, Nuffield Department of Primary Care Health Sciences, Medical Sciences Division
[5] University of Nottingham,Division of Primary Care
来源
BMC Cancer | / 21卷
关键词
Cancer; Hormone replacement therapy; Mortality; Cardiovascular disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 98 条
[1]  
Ameye L(2014)Menopausal hormone therapy use in 17 European countries during the last decade Maturitas. 79 287-291
[2]  
Antoine C(2016)2016 IMS recommendations on womens midlife health and menopause hormone therapy Climacteric. 19 109-150
[3]  
Paesmans M(2011)American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause Endocr Pract 17 1-25
[4]  
De Azambuja E(2016)Menopause management — getting clinical care Back on track N Engl J Med 374 803-806
[5]  
Rozenberg S(2016)Best practice for HRT: unpicking the evidence Br J Gen Pract 66 597-598
[6]  
Baber RJ(2017)American Association of Clinical Endocrinologists and American College of endocrinology position statement on menopause–2017 update Endocr Pract 23 869-880
[7]  
Panay N(2004)Hormone replacement therapy in cancer survivors Maturitas. 48 333-346
[8]  
Fenton A(2016)Menopausal hormone therapy in cancer survivors: a narrative review of the literature Maturitas. 92 86-96
[9]  
Goodman NF(2008)Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma Endocr Relat Cancer 15 475-483
[10]  
Cobin RH(2015)Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis Int J Cancer 136 2369-2377